Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) is a clinical research site located in Chicago, Illinois, United States 60611.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) has 1 clinical trials on record, with 1 currently active. Their work covers Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease.
Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.